Abstract |
Twenty-one nongonococcal urethritis patients by Chlamydia trachomatis infection were treated with doxycycline (DOXY, Vibramycin) 200 mg/day orally for 2 weeks. The age of these patients were ranged from 17 to 52. C. trachomatis was eradicated 8(89%) of 9 cases on 3rd day and never reisolated on 7th day after treatment. Ten (83%) of 12 patients on 7th day and any patients on 14th day were not suffered from symptoms after treatment. Urethral discharge was not seen macroscopically, 11 (92%) of 12 patients on 7th day and any patients on 14th day. According to the criteria for urethritis requiring at least 4 WBC per high power field in urethral smear and/or first voided urine, the overall clinical efficacy rate was 44% (4/9) on 3rd day, 83% (10/12) on 7th day and 100% (9/9) on 14th day. No side effects were recognized in any cases. In conclusion, DOXY was thought to be useful and safe drug in the treatment of nongonococcal urethritis by C. trachomatis.
|
Authors | Y Ito, N Katoh, A Takeda, M Kanematsu, Y Ban, T Nishiura, S Sakai, S Fujihiro, T Doi, K Tei |
Journal | The Japanese journal of antibiotics
(Jpn J Antibiot)
Vol. 39
Issue 1
Pg. 9-16
(Jan 1986)
ISSN: 0368-2781 [Print] Japan |
PMID | 3084830
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Chlamydia Infections
(drug therapy)
- Chlamydia trachomatis
(isolation & purification)
- Doxycycline
(therapeutic use)
- Follow-Up Studies
- Gonorrhea
(drug therapy)
- Humans
- Male
- Middle Aged
- Neisseria gonorrhoeae
(isolation & purification)
- Pyuria
(drug therapy)
- Time Factors
- Urethritis
(drug therapy)
- Urine
(microbiology)
|